sk&f 89124 has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (sk&f 89124) | Trials (sk&f 89124) | Recent Studies (post-2010) (sk&f 89124) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
14 | 0 | 0 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Lokhandwala, MF; Sakamoto, T | 1 |
1 other study(ies) available for sk&f 89124 and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Attenuation of adenylate cyclase-induced increases in renal sodium excretion by the dopamine D-2 receptor agonist SK&F 89124.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Colforsin; Domperidone; Hemodynamics; Indoles; Kidney; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sodium | 1994 |